3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Colorectal Neoplasms
2
Solid Malignant Tumors
1
Recurrence
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Glioblastoma
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
Temozolomide
9
Specimen Handling
6
Radiotherapy
6
Magnetic Resonance Spectroscopy
6
Radiation
5
trametinib
2
dabrafenib
2
Radiotherapy, Intensity-Modulated
2
Bevacizumab
2
vorasidenib
1
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
ribociclib
1
Vorinostat
1
Spinal Puncture
1
Protons
1
Proton Therapy
1
Pluvicto
1
Nivolumab
1
Magnetic Resonance Imaging
1
Leukapheresis
1
Irinotecan
1
Ipilimumab
1
Flucytosine
1
Everolimus
1
DNA
1
Carmustine
1
Carboplatin
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
regorafenib
×
30 days
×
Clear all
No trials found.